Sheep Poo Study Reveals New Insights Into Facial Eczema Risk Across New Zealand
The Eliminating Facial Eczema Impacts programme recently hosted a webinar about the progress the sheep poo study has made in helping understand facial eczema (FE).
FACIAL ECZEMA (FE) is a disease with a huge economic impact in the warm humid areas of New Zealand, points out Robin Pharmaceuticals, maker of the FiltaBac treatment for the disease.
FE affects dairy and beef cattle of all ages, younger animals being more susceptible, sheep and red deer also being affected by Pithomyces chartarum fungal spores.
Prevention is always paramount in managing productivity however the problem grows when physical (clinical) symptoms of FE appear: the extreme damaging effects from the Sporidesmin toxin causes liver damage, which can then lead to photosensitisation of the white or non-pigmented skin on cattle and sheep.
Photosensitivity occurs because the FE damaged liver cannot remove wastes and a breakdown product of grass pigments (chlorophyll) accumulates. The non-pigmented or thin skin thickens, cracks, peels and causes pain. Cows are restless at milking time, seek shade and lick their udders.
In some cases the teats and udder become so severely damaged it is impossible to milk the affected quarter of the cow.
FiltaBac Cream was formulated by Robin Pharmaceuticals Ltd in 1971, has been registered with the Animal Remedies Board since then, and has proved effective in alleviating the extreme skin damaging effects of facial eczema.
Robin Pharmaceuticals chief executive Samantha Sinclair attributes FiltaBac cream’s effectiveness to its sun and light blocking action achieved by the high percentage of non-absorbed, inert mineral compounds titanium dioxide and zinc oxide in the cream. These two sun-blockers, combined with the anti-bacterial qualities of the cetrimide and benzalkonium chloride, calm the skin and promote wound healing, Sinclair says.
“What also happens when FiltaBac is applied onto the damaged skin area is that there is an almost immediate soothing, pain relief reaction,” she says.
“This allows for the affected quarter(s) to be protected like a second skin covering and at the following milking, after cleansing the area, the affected quarters could be milked. Following this method does not produce milk grades.
“The real benefit is the barrier cover FiltaBac Cream provides, simulating the properties of undamaged skin, allowing for moist wound healing, preserving the new skin cells, allowing them to breathe and maintain correct moisture levels.”
www.aniwell-nz.com
Fonterra has lifted and narrowed its full year forecast earnings range to 60-70 cents per share after a strong quarter, supported by robust milk production, strong shipment volumes and continued demand across its Ingredients and Foodservice businesses.
Fonterra has announced it will continue with the planned expansion of its organic business into the South Island.
New Zealand farmers have been told they all have amazing people on their farms and have been urged to be “that one person” that can make a huge difference to those going through tough times.
OPINION: For thousands of Southland farmers, this week would have tipped them into the non-compliant category when it comes to following regional freshwater plan rules. But the Government has stepped in to give them the clarity they deserve.
The stark realities of the world trade that New Zealand is having to face have been revealed by Trade Minister Todd McClay.
New Zealand and the European Union are closer than ever.
OPINION: Reckless action by Greenpeace in 2024 forced Fonterra to shut down a drying plant for four hours, costing the co-op…
OPINION: The global crusade against fossil fuel is gaining momentum in some regions.